<code id='2DB2CF7D83'></code><style id='2DB2CF7D83'></style>
    • <acronym id='2DB2CF7D83'></acronym>
      <center id='2DB2CF7D83'><center id='2DB2CF7D83'><tfoot id='2DB2CF7D83'></tfoot></center><abbr id='2DB2CF7D83'><dir id='2DB2CF7D83'><tfoot id='2DB2CF7D83'></tfoot><noframes id='2DB2CF7D83'>

    • <optgroup id='2DB2CF7D83'><strike id='2DB2CF7D83'><sup id='2DB2CF7D83'></sup></strike><code id='2DB2CF7D83'></code></optgroup>
        1. <b id='2DB2CF7D83'><label id='2DB2CF7D83'><select id='2DB2CF7D83'><dt id='2DB2CF7D83'><span id='2DB2CF7D83'></span></dt></select></label></b><u id='2DB2CF7D83'></u>
          <i id='2DB2CF7D83'><strike id='2DB2CF7D83'><tt id='2DB2CF7D83'><pre id='2DB2CF7D83'></pre></tt></strike></i>

          
          WSS
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

          The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

          advertisement

          Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          fashion